GrowingStockReport.com

NASDAQ Gainers Watch List: Biogen Idec Inc. (NASDAQ:BIIB) and Mylan, Inc. (NASDAQ:MYL) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 06/14/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Biogen Idec Inc. (NASDAQ:BIIB) and Mylan, Inc. (NASDAQ:MYL).

Biogen Idec Inc. (NASDAQ:BIIB) a company that discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally is currently up (+0.40%) on 911,791 shares traded. Biogen Idec Inc. (NASDAQ:BIIB) is currently up (+62.42%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Biogen Idec Inc. (NASDAQ:BIIB)

Mylan, Inc. (NASDAQ:MYL) a company that engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients worldwide is currently up (+0.19%) on 1,086,865 shares traded. Mylan, Inc. (NASDAQ:MYL) is currently up (+56.1%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Mylan, Inc. (NASDAQ:MYL)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com